Cargando…
Structural basis of receptor usage by the engineered capsid AAV-PHP.eB
Adeno-associated virus serotype 9 (AAV9) is a promising gene therapy vector for treating neurodegenerative diseases due to its ability to penetrate the blood-brain barrier. PHP.eB was engineered from AAV9 by insertion of a 7-amino acid peptide and point mutation of neighboring residues, thereby enha...
Autores principales: | Jang, Seongmin, Shen, Hao K., Ding, Xiaozhe, Miles, Timothy F., Gradinaru, Viviana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382559/ https://www.ncbi.nlm.nih.gov/pubmed/36034770 http://dx.doi.org/10.1016/j.omtm.2022.07.011 |
Ejemplares similares
-
AAV-PHP.eB transduces both the inner and outer retina with high efficacy in mice
por: Palfi, Arpad, et al.
Publicado: (2022) -
CNS Transduction Benefits of AAV-PHP.eB over AAV9 Are Dependent on Administration Route and Mouse Strain
por: Mathiesen, Sophie N., et al.
Publicado: (2020) -
Pilot Study Assessing the Impact of Intrathecal Administration of Variants AAV-PHP.B and AAV-PHP.eB on Brain Transduction in Adult Rhesus Macaques
por: Arotcarena, Marie-Laure, et al.
Publicado: (2021) -
Widespread labeling and genomic editing of the fetal central nervous system by in utero CRISPR AAV9-PHP.eB administration
por: Hu, Shuntong, et al.
Publicado: (2021) -
Apolipoprotein E, low-density lipoprotein receptor, and immune cells control blood-brain barrier penetration by AAV-PHP.eB in mice
por: Xie, Bao-Shu, et al.
Publicado: (2021)